CM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
IPO Year:
Exchange: NASDAQ
Fastest customizable press release news feed in the world
Business combination with CM Life Sciences III results in approximately $1.3 billion in cash proceedsCombined company to trade on Nasdaq Global Market under ticker "EQRX" NEW YORK and CAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences III (NASDAQ:CMLT, CMLTW, CMLTU))), a life science-focused special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, and EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the completion of their business combination. The business combination was approved by CM Life S
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - EQRx, Inc. (0001843762) (Issuer)
3 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
3 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
4 - EQRx, Inc. (0001843762) (Issuer)
EFFECT - EQRx, Inc. (0001843762) (Filer)
424B3 - EQRx, Inc. (0001843762) (Filer)
S-1 - EQRx, Inc. (0001843762) (Filer)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
425 - CM Life Sciences III Inc. (0001843762) (Subject)
EFFECT - CM Life Sciences III Inc. (0001843762) (Filer)
424B3 - CM Life Sciences III Inc. (0001843762) (Filer)
S-4/A - CM Life Sciences III Inc. (0001843762) (Filer)
This live feed shows all institutional transactions in real time.
SC 13D - EQRx, Inc. (0001843762) (Subject)
SC 13D - EQRx, Inc. (0001843762) (Subject)
SC 13G - CM Life Sciences III Inc. (0001843762) (Subject)